Nordic BioVentures ApS: Financial statements 2023
CVR: 43852116
Source: annual report 2023, Danish Business Authority
06/02/2023 – 31/12/2023
Nordic BioVentures ApS (CVR 43852116) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,281,448 and a net result of DKK 1,470,607. Equity in the 2023 report amounted to DKK 1,470,607. The solvency ratio was 70%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,281,448
- Profit/Loss
- DKK 1,470,607
- Equity
- DKK 1,470,607
- Total Assets
- DKK 2,101,702
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of February 6, 2023, Josephine Schrøder Warming has joined the board of directors of Nordic BioVentures ApS.
As of February 6, 2023, William Comstive Wright Nilsen has joined the board of directors of Nordic BioVentures ApS.
As of February 6, 2023, Josephine Schrøder Warming is registered as director of Nordic BioVentures ApS.
As of February 6, 2023, William Comstive Wright Nilsen is registered as director of Nordic BioVentures ApS.
Nordic BioVentures ApS was founded on February 6, 2023.
About Nordic BioVentures ApS
Nordic BioVentures ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Nordic BioVentures 1 AMBA and Nordic BioVentures AMBA. The management consists of Josephine Schrøder Warming and William Comstive Wright Nilsen. The company is owned by Warming Ventures ApS and Wright Ventures ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 1,512,110 and a net result of DKK -1,291,767 compared with DKK 265,974 the year before. Equity in the 2025 report amounted to DKK 444,815.
